Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Antimuscarinic Drugs on the Cognition of Patients With Acute Spinal Cord Injury

NCT01600404 is registered in ClinicalTrials.gov with Swiss Paraplegic Research, Nottwil as lead sponsor.

NCT NCT01600404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01600404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Antimuscarinic Drugs on the Cognition of Patients With Acute Spinal Cord Injury
Lead sponsor
Swiss Paraplegic Research, Nottwil
Phase
Observational
Overall status
Completed
Start date
December 31, 2011
Completion date
November 30, 2015
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment, spinal cord injuries